Interactions of biomolecules with inorganic materials: principles, applications and future prospects

Abstract

The goal of this article is to overview the current understanding of biomolecule-inorganic materials interactions; to identify the 'rules' that govern interaction; to highlight the drawbacks of the present approaches and outline future challenges and opportunities.Please check this proof carefully. Our staff will not read it in detail after you have returned it. Translation errors between word-processor files and typesetting systems can occur so the whole proof needs to be read. Please pay particular attention to: tabulated material; equations; numerical data; figures and graphics; and references. If you have not already indicated the corresponding author(s) please mark their name(s) with an asterisk. Please e-mail a list of corrections or the PDF with electronic notes attached -do not change the text within the PDF file or send a revised manuscript.Please bear in mind that minor layout improvements, e.g. in line breaking, table widths and graphic placement, are routinely applied to the final version.We will publish articles on the web as soon as possible after receiving your corrections; no late corrections will be made.Please return your final corrections, where possible within 48 hours of receipt, by e-mail to: proofs@rsc.org Electronic (PDF) reprints will be provided free of charge to the corresponding author. Enquiries about purchasing paper reprints should be addressed via: http://www.rsc.org/Publishing/ReSourCe/PaperReprints/. Costs for reprints are below: Interactions between inorganic materials and biomolecules at the molecular level, although complex, are commonplace. Examples include biominerals, which are, in most cases, facilitated by and in contact with biomolecules; implantable biomaterials; and food and drug handling. The effectiveness of these functional materials is dependant on the interfacial properties i.e. the extent of molecular level 'association' with biomolecules. The goal of this overview is four-fold: to present biomolecule-inorganic materials interactions and our current understanding using selected examples; to elaborate on approaches that have been used to expose the mechanisms underpinning such interactions; to identify the 'rules' or 'guiding principles' that govern interactions that could be used to explain and hence predict behaviour; and finally to highlight the drawbacks of the present approaches and outline future challenges and opportunities. Reprint costs

Dispersion corrected DFT approaches for anharmonic vibrational frequency calculations: nucleobases and their dimers

“…[1][2][3][4][5][6][7][8] . A comprehensive analysis of the properties of these systems could be very useful for designing highly biocompatible materials and specific biosensors [9][10][11][12][13][14] .…”

First principles determination of structural, electronic and lattice dynamical properties of a model dipeptide molecular crystal

“…biosensors and bioarrays [21][22][23][24], whilst peptide-inorganic interfaces offer novel means of materials synthesis and nanoscale fabrication [25][26][27][28]. The common theme underpinning these disparate research avenues is the desire to develop, at the molecular level, a detailed and accurate description of the intermolecular interactions responsible for these phenomena and to thereby elucidate the relationship between peptide structure and function.…”

Direct evidence of ZnO morphology modification via the selective adsorption of ZnO-binding peptides

“…Although there are limitations to this approach, 60,61 a number of metal-binding peptides (M-BPs) [62][63][64][65] and metal oxide-binding peptides (MO-BPs) 46,58,[66][67][68][69][70] have been identified that have either been shown to have an affinity for the surface they were isolated from or have been shown to influence the growth of their respective metal or metal oxide. The identification of ZnO-binding peptides (ZnO-BPs) and understanding how they adhere to the surface of ZnO is potentially useful for the construction of artificial biomaterials, medical implants, and biosensors where biocompatibility is required.…”